Live Chat Software
05 - 07 November, 2019 | Hilton London Olympia , London, United Kingdom
Peter Rutherford, Global Medical Lead Orphan Unit at Vifor Pharma
Vifor Pharma Logo

Peter Rutherford


Global Medical Lead Orphan Unit
Vifor Pharma

Check out the incredible speaker line-up to see who will be joining Peter.

Download The Latest Agenda

Conference Day One

Tuesday, November 5th, 0019


4:20 PM Meeting Unmet Patient Needs and Showing it Through Data

  • Discuss the internal communication issues that arise when conducting an Early Access Programme and the need to differentiate from a clinical trial, in the context of rare and orphan disease
  • Explore both the internal and external challenges and opportunities associated with the capture of real world data, and how it can be achieved in clinical practice
  • Examine how this secondary purpose of early access programmes can be utilised to guide benefit risk management, life cycle planning and hypothesis testing while still adhering to the basic premise of meeting an unmet medical need

4:55 PM Break-Out Discussions

  1. Managing Varying Stakeholder Perspectives and Effective Communication - Peter Rutherford,  Global Medical Lead Orphan Unit, Vifor Pharma
  2. Vendor Validation and Qualification: Managing an Outsourced EMAP
  3. Building an Effective and Collaborative Relationship with your Stakeholders
  4. Understanding the quirks of Pediatric Early Access Programmes - Alison Batement-House, Co-Chair, NYU Working Group on Compassionate Use and Preapproval Access (CUPA)